⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4381020 | 1.00 | — | — | |
| SCHEMBL5026514 | 1.00 | — | — | |
| SCHEMBL31048256 | 0.94 | CREBBP (0.36) | — | |
| SCHEMBL2984642 | 0.94 | CREBBP (0.36) | — | |
| SCHEMBL210597 | 0.86 | — | — | |
| SCHEMBL210598 | 0.86 | — | — | |
| SCHEMBL223376 | 0.86 | — | — | |
| SCHEMBL2994987 | 0.85 | IRAK4 (0.33) | — | |
| SCHEMBL2989773 | 0.82 | IRAK4 (0.32) | — | |
| SCHEMBL16611587 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 119 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118563582-A | Penetrating fluid for ink-jet printing and ink-jet recording method | 精工爱普生株式会社 | 2024-08-30 | — | — | CN | claimed |
| US-20240287344-A1 | Ink Jet Printing Penetrant And Ink Jet Recording Method | SEIKO EPSON CORPORATION (JP) | 2024-08-29 | — | — | US | claimed |
| WO-2025226892-A1 | SPIROCYCLE-CONTAINING DIAMINOMETHYLENE PYRIMIDINE-2,4,6-TRIONE AGONISTS OF PARATHYROID HORMONE 1 AND INCRETIN RECEPTORS | SEPTERNA, INC. (US) | 2025-10-30 | — | — | WO | disclosed |
| CN-118563582-A | Penetrating fluid for ink-jet printing and ink-jet recording method | 精工爱普生株式会社 | 2024-08-30 | — | — | CN | disclosed |
| US-20240287344-A1 | Ink Jet Printing Penetrant And Ink Jet Recording Method | SEIKO EPSON CORPORATION (JP) | 2024-08-29 | — | — | US | disclosed |
| EP-3919056-B1 | COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN | GLOBAL BLOOD THERAPEUTICS INC (US) | 2024-08-28 | — | — | EP | disclosed |
| US-20240101553-A1 | KRAS G12C INHIBITORS | MIRATI THERAPEUTICS INC (US) | 2024-03-28 | — | — | US | disclosed |
| CN-117396476-A | Substituted phenyl-1H-pyrrolo [2,3-c ] pyridine derivatives | 詹森药业有限公司 | 2024-01-12 | — | — | CN | disclosed |
| US-20230373999-A1 | KRAS G12C INHIBITORS | MIRATI THERAPEUTICS INC (US) | 2023-11-23 | — | — | US | disclosed |
| US-20230339970-A1 | CASEIN KINASE 1 DELTA MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2023-10-26 | — | — | US | disclosed |
| US-20230339970-A1 | CASEIN KINASE 1 DELTA MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2023-10-26 | — | — | US | disclosed |
| EP-1373269-B1 | JUN KINASE INHIBITORS | EISAI CO LTD (JP) | 2005-06-08 | — | — | EP | disclosed |
| WO-2004108215-A1 | PIPERIDINYL PROSTAGLANDIN E ANALOGS | ALLERGAN, INC. (US) | 2004-12-16 | — | — | WO | disclosed |
| US-20040248854-A1 | Piperidinyl prostaglandin E analogs | ALLERGAN, INC. | 2004-12-09 | — | — | US | disclosed |
| US-20040235864-A1 | Jun kinase inhibitors | EISAI R & D MANAGEMENT CO., LTD. (JP) | 2004-11-25 | — | — | US | disclosed |
| WO-2004094382-A1 | MUSCARINIC AGONISTS | ELI LILLY AND COMPANY (US) | 2004-11-04 | — | — | WO | disclosed |
| WO-2004063158-A1 | 2-PIPERIDONE DERIVATIVES AS PROSTAGLANDIN AGONISTS | F.HOFFMANN-LA ROCHE AG (CH) | 2004-07-29 | — | — | WO | disclosed |
| US-20040142969-A1 | 2-Piperidone derivatives as prostaglandin agonists | ROCHE PALO ALTO LLC | 2004-07-22 | — | — | US | disclosed |
| US-6747037-B1 | TREATING OCULAR HYPERTENSION OR GLAUCOMA; REDUCED SIDE EFFECTS | ALLERGAN, INC. | 2004-06-08 | — | — | US | disclosed |
| US-4326071-A | ENZYME INHIBITORS AND ANTIBIOTICS | MERRELL TORAUDE ET COMPAGNIE (FR) | 1982-04-20 | — | — | US | disclosed |